Revvity announces launch of three Mimix reference standards for IVD use

Revvity (RVTY) announced the launch of three Mimix reference standards for IVD use, designed for monitoring of next-generation sequencing, NGS, or droplet digital polymerase chain reacting, ddPCR, assays designed to detect somatic mutations in genomic DNA, gDNA, from human samples for IVD use. These cell line-derived reference standards have undergone appropriate design controls to meet U.S. Food and Drug Administration, FDA, regulatory requirements, which helps laboratories integrate them into existing workflows to support monitoring test performance, assay variation, and to help identify increases in random or systemic errors.